A robotics PhD student in Munich unboxes a two-legged machine, swaps its feet from wheels to point-tips in a few minutes, and watches it walk. The robot was not built in Boston or Tokyo. It shipped from a Shenzhen startup that, three years earlier, barely existed — and whose backers now include some of China's heaviest corporate names.
LimX Dynamics (逐际动力) was founded in January 2022 by Zhang Wei (张巍), a professor at the Southern University of Science and Technology (南方科技大学) and former associate professor at Ohio State University. The company's bet is unusual: instead of chasing a headline humanoid, it first shipped a multi-form bipedal robot (多形态双足机器人) aimed at researchers, then used that revenue and attention to fund a push into full humanoids.
One machine, three ways to walk
The product is called TRON 1. Launched for sale in October 2024 with simultaneous release in China and overseas, its pre-order price started at RMB 69,800 (about $9,800 / HK$76,100) — far below the high-five-figure sums full-size humanoid development platforms command. Its signature feature is a "three-in-one" modular foot-end design: a point-foot for simple control, a sole for humanoid-like walking, and a wheeled foot for efficient all-terrain travel. Users swap ends quickly, and the robot auto-detects the mode.
This is deliberately a research platform, not a home appliance. LimX ships an open SDK, supports Python for full development, and offers one-click Sim2Real deployment so reinforcement-learning algorithms validated in simulation (NVIDIA Isaac, Mujoco, Gazebo) can run on the real machine. The pitch to universities and labs is simple: one physical body, many locomotion experiments, low barrier to entry.
Why researchers, not households, are the first buyers
Most bipeds announced today are enterprise demos or lab prototypes. TRON 1's distinction is that it was sold, with reservations opened to developers, universities and commercial R&D teams. That matters because the hardest unsolved problem in robotics is not building one impressive machine — it is building a machine whose locomotion and control generalize across floors, curbs, stairs and clutter.
LimX pairs the hardware with algorithm work. It has published LimX VGM, an embodied-manipulation method that uses video generation to improve how a robot's "brain" learns, and it emphasizes reinforcement-learning-based whole-body motion control (全身运动控制) — the "cerebellum" that keeps a legged machine upright and efficient. The company says its three core threads are hardware design and manufacturing, RL-based cerebellar control, and embodied-brain model training.
The Alibaba vote of confidence
In March 2025, LimX announced an A+ round that brought its A-series financing to RMB 500 million (about $70 million / HK$545 million) within half a year. The investor list reads like a who's-who of Chinese strategic capital: Alibaba, China Merchants Venture (招商局创投), Shangqi Capital (尚颀资本, tied to SAIC), NIO Capital (蔚来资本) and Lenovo Capital, among others. Earlier, a 2023 angel and Pre-A round totaled roughly RMB 200 million (around $28 million / HK$218 million), and a July 2024 A round was led by Alibaba and China Merchants — notably Alibaba's first known investment in a humanoid-robot company.
For a startup, that backing is a signal about where the money thinks locomotion and embodied AI will pay off: not necessarily in a humanoid that folds your laundry, but in platforms and toolchains that let many developers teach machines to move and act.
From a walking platform to a full humanoid
LimX has not stopped at the research biped. Through 2025 and 2026 it iterated full-size humanoids and, in May 2026, unveiled LimX Luna, a full-size interactive humanoid, alongside a "brain" system called COSA (updated to version 0.5 in July 2026). In July 2026 the company also disclosed a Pre-IPO round. The arc is clear: prove locomotion and a developer ecosystem with TRON 1, then climb toward a general-purpose humanoid.
That sequencing is the opposite of the typical hype curve. Rather than reveal a polished humanoid and hope for orders, LimX monetized the hard middle step — reliable, configurable bipedal movement — and let research revenue and strategic capital fund the climb.
Honest limitations
TRON 1's launch (October 2024) and price (from RMB 69,800) are confirmed by the company's own release and by China Securities/China Economic News coverage; this is a 2024 product still being commercialized, not a 2025–2026 debut. The RMB 500 million A-series, the RMB 200 million angel/Pre-A, and the Alibaba-led July 2024 A round are reported by Securities Times (证券时报) and corroborating outlets, but remain company-announced funding figures. The Luna humanoid, COSA 0.5, and the July 2026 Pre-IPO round are stated on LimX's own website and were not independently audited here. "World's first multi-form bipedal robot" is the company's marketing claim; similar modular bipeds exist from other labs, so the superlative should be read narrowly as LimX's commercial framing rather than a verified absolute. TRON 1 is explicitly a technical/research product, not a consumer robot, and its real-world autonomy on stairs and clutter is still operator-assisted in many cases.
What readers can do now
- If you follow robotics investing, separate "humanoid reveal" news from "robot actually sold" news — LimX's TRON 1 is in the rarer second category, and that is the more meaningful signal.
- University and lab readers can treat sub-$10,000 modular bipeds like TRON 1 as a legitimate entry point for locomotion and Sim2Real research, provided you budget for the SDK learning curve.
- Watch which embodied-AI startups attract strategic (Alibaba, SAIC, NIO) rather than purely financial backers — that split often predicts who gets real deployment partners.